Catalent issues open letter to customers
MLex Summary: Drug manufacturer Catalent has issued an open letter to its customers, to reassure them that after its acquisition by Novo Holdings closes, it will continue to serve as a...To view the full article, register now.
Already a subscriber? Click here to view full article